Inactive Instrument
Kancera AB Stock
Stocks
NOVKAN
SE0015658570
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -43.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Olin
CEO | Chief Executive Officer | 68 | 2010-05-04 |
Robert Edfors
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-31 |
Maria Sahlberg
CMP | Compliance Officer | 44 | 2024-05-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | - | |
Thomas Olin
BRD | Director/Board Member | 68 | 2010-05-04 |
| Director/Board Member | 60 | 2018-05-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/25/21 | Free | Chairman | 33,150 | 0.0594% | ||
| 5/21/21 | Buy | Director | 7,710 | - | ||
| 5/21/21 | Others | Chairman | 18,183 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -43.95% | -50.98% | - | - | 330K | |
| -1.38% | +0.20% | +46.42% | +96.33% | 69.18B | |
| -0.44% | -1.18% | +35.59% | +75.13% | 62B | |
| -4.29% | -3.98% | -16.22% | +350.66% | 26.19B | |
| +1.46% | +2.25% | +28.84% | +14.54% | 25.75B | |
| -2.20% | -2.00% | -1.22% | -14.48% | 24.29B | |
| +3.21% | +4.08% | +25.16% | -14.68% | 19.84B | |
| +1.26% | -14.23% | +170.04% | +298.75% | 15.65B | |
| -5.54% | +0.69% | -8.13% | +830.48% | 13.88B | |
| -0.39% | -4.24% | -9.86% | +454.94% | 14.09B | |
| Average | -5.22% | -2.20% | +30.07% | +232.41% | 30.1B | |
| Weighted average by Cap. | -0.92% | -1.32% | +31.81% | +158.20% |
Employees
5
Calendar
